The protein STK17A (serine threonine kinase 17A) appears to play roles in various cancer types. It can be oncogenic or tumor suppressive, depending on the cancer, but its role in colorectal cancer has not been established. Christopher Williams, MD, PhD, Sarah Short, PhD, and colleagues observed that STK17A expression is reduced in primary colorectal tumors...